Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conrad Russell Y Cruz

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cytotherapy|October 18, 2016
Gene-modified, cell-based therapies-an overviewAllison B Powell, Kiara Williams, Conrad Russell Y Cruz
Nanomedicine (London, England)|July 9, 2016
Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapyRachel A Burga, Shabnum Patel, Catherine M Bollard, et al.
Transplantation and Cellular Therapy|October 2, 2020
NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming LimitationsCarlos E Sanchez, Ehsan P Dowlati, Ashley E Geiger, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 10, 2016
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastomaJuliana Cano-Mejia, Rachel A Burga, Elizabeth E Sweeney, et al.
Cytotherapy|January 15, 2018
Human papilloma virus-specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patientsSarah E McCormack, Conrad Russell Y Cruz, Kaylor E Wright, et al.
Journal of Virology|July 22, 2022
The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT ActivationAmanda B Macedo, Callie Levinger, Bryan N Nguyen, et al.
Frontiers in Oncology|April 27, 2019
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against CancerShabnum Patel, Rachel A Burga, Allison B Powell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2022
The generation and application of antigen-specific T cell therapies for cancer and viral-associated diseaseAmy B Hont, Allison B Powell, Danielle K Sohai, et al.
Bioengineering & Translational Medicine|May 31, 2024
Photothermal Prussian blue nanoparticles generate potent multi-targeted tumor-specific T cells as an adoptive cell therapyElizabeth E Sweeney, Palak Sekhri, Nethaji Muniraj, et al.
International Journal of Nanomedicine|July 31, 2023
Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIVJoshua Ghofrani, Allan Bowen, Jie Chen, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cytotherapy|October 18, 2016
Gene-modified, cell-based therapies-an overviewAllison B Powell, Kiara Williams, Conrad Russell Y Cruz
Nanomedicine (London, England)|July 9, 2016
Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapyRachel A Burga, Shabnum Patel, Catherine M Bollard, et al.
Transplantation and Cellular Therapy|October 2, 2020
NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming LimitationsCarlos E Sanchez, Ehsan P Dowlati, Ashley E Geiger, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 10, 2016
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastomaJuliana Cano-Mejia, Rachel A Burga, Elizabeth E Sweeney, et al.
Cytotherapy|January 15, 2018
Human papilloma virus-specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patientsSarah E McCormack, Conrad Russell Y Cruz, Kaylor E Wright, et al.
Journal of Virology|July 22, 2022
The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT ActivationAmanda B Macedo, Callie Levinger, Bryan N Nguyen, et al.
Frontiers in Oncology|April 27, 2019
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against CancerShabnum Patel, Rachel A Burga, Allison B Powell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2022
The generation and application of antigen-specific T cell therapies for cancer and viral-associated diseaseAmy B Hont, Allison B Powell, Danielle K Sohai, et al.
Bioengineering & Translational Medicine|May 31, 2024
Photothermal Prussian blue nanoparticles generate potent multi-targeted tumor-specific T cells as an adoptive cell therapyElizabeth E Sweeney, Palak Sekhri, Nethaji Muniraj, et al.
International Journal of Nanomedicine|July 31, 2023
Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIVJoshua Ghofrani, Allan Bowen, Jie Chen, et al.
Pageof 3